DE13731071T1 - Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen - Google Patents

Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen Download PDF

Info

Publication number
DE13731071T1
DE13731071T1 DE13731071.0T DE13731071T DE13731071T1 DE 13731071 T1 DE13731071 T1 DE 13731071T1 DE 13731071 T DE13731071 T DE 13731071T DE 13731071 T1 DE13731071 T1 DE 13731071T1
Authority
DE
Germany
Prior art keywords
stained cells
cells
tumor
stained
cd45ro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE13731071.0T
Other languages
German (de)
English (en)
Inventor
Jérôme GALON
Bernhard Mlecnik
Franck PAGÈS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris Descartes
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, Institut National de la Sante et de la Recherche Medicale INSERM, Universite Paris Descartes filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of DE13731071T1 publication Critical patent/DE13731071T1/de
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/575
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE13731071.0T 2012-06-14 2013-06-14 Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen Pending DE13731071T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
WOPCT/IB2012/001446 2012-06-14
IB2012001446 2012-06-14
EP13731071.0A EP2861986B1 (en) 2012-06-14 2013-06-14 Method for quantifying immune cells in tumoral tissues and its applications
PCT/EP2013/062405 WO2013186374A1 (en) 2012-06-14 2013-06-14 Method for quantifying immune cells in tumoral tissues and its applications

Publications (1)

Publication Number Publication Date
DE13731071T1 true DE13731071T1 (de) 2016-08-18

Family

ID=46881097

Family Applications (1)

Application Number Title Priority Date Filing Date
DE13731071.0T Pending DE13731071T1 (de) 2012-06-14 2013-06-14 Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen

Country Status (13)

Country Link
US (1) US10317408B2 (enExample)
EP (1) EP2861986B1 (enExample)
JP (1) JP6449765B2 (enExample)
KR (1) KR102179848B1 (enExample)
CN (1) CN104541167B (enExample)
AU (1) AU2013276470B2 (enExample)
BR (1) BR112014031143B8 (enExample)
CA (1) CA2873278C (enExample)
DE (1) DE13731071T1 (enExample)
ES (1) ES2902879T3 (enExample)
IL (1) IL235738B (enExample)
SG (1) SG11201408107RA (enExample)
WO (1) WO2013186374A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2701092T5 (es) 2014-02-24 2022-05-12 Ventana Med Syst Inc Procedimientos, kits y sistemas para puntuar la respuesta inmunitaria al cáncer por detección simultánea de CD3, CD8, CD20 y FOXP3
EP3195191B1 (en) * 2014-09-03 2020-10-21 Ventana Medical Systems, Inc. Systems and methods for calculating immune scores
CN107109459A (zh) * 2014-11-05 2017-08-29 加利福尼亚大学董事会 用于分层对阻断pd1/pdl1轴的疗法的无响应者的方法
CA2973878A1 (en) 2015-01-22 2016-07-28 University Of Massachusetts Cancer immunotherapy
CN113671186A (zh) * 2015-10-23 2021-11-19 诺华股份有限公司 对包含肿瘤组织的样品评分的方法
MX393482B (es) * 2016-05-09 2025-03-24 Inst Nat Sante Rech Med Metodos para clasificar pacientes con un cancer solido
US11315240B2 (en) * 2016-05-18 2022-04-26 Hoffmann-La Roche Inc. System and method of tumor classification
WO2018027223A1 (en) * 2016-08-05 2018-02-08 Duke University Camkk2 inhibitor compositions and methods of using the same
EP3532984B1 (en) * 2016-10-27 2024-05-08 Koninklijke Philips N.V. Apparatus for determining cellular composition information in one or more tissue samples
WO2018081817A2 (en) 2016-10-31 2018-05-03 University Of Massachusetts Targeting microrna-101-3p in cancer therapy
CN106846310A (zh) * 2017-01-19 2017-06-13 宁波江丰生物信息技术有限公司 一种基于免疫组化技术的病理辅助分析方法
EP3659110A1 (en) * 2017-07-24 2020-06-03 Ventana Medical Systems, Inc. Methods and systems for evaluation of immune cell infiltrate in tumor samples
US11814623B2 (en) 2018-01-30 2023-11-14 University Of Massachusetts Methods of treating a wound using epigenetic regulation
WO2019149817A1 (en) 2018-01-31 2019-08-08 Ventana Medical Systems, Inc. Methods and systems for evaluation of immune cell infiltrate in stage iii colorectal cancer
EP3921648A1 (en) * 2019-02-05 2021-12-15 Ventana Medical Systems, Inc. Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer
US20220236276A1 (en) 2019-06-03 2022-07-28 Inserm (Institut National De La Santé Et De La Recherch Médicale Methods for modulating a treatment regimen
AU2020378280A1 (en) 2019-11-07 2022-04-07 Feng Biosciences, Ltd. Classification of tumor microenvironments
CN111551546B (zh) * 2020-06-01 2023-01-03 南京瑟斯检测科技有限公司 一种基于光学微腔结构超材料的免疫组化便捷检测方法
EP4172628A1 (en) * 2020-06-30 2023-05-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapy and radical surgery
CN115997123A (zh) 2020-06-30 2023-04-21 国家医疗保健研究所 用于预测实体癌患者在术前辅助治疗后复发和/或死亡风险的方法
TWI838687B (zh) * 2021-01-30 2024-04-11 奇美醫療財團法人奇美醫院 評估腫瘤標本免疫狀態的方法
CN113092202A (zh) * 2021-03-25 2021-07-09 上海福君基因生物科技有限公司 一种胃癌预后预测装置
CN113515077A (zh) * 2021-04-23 2021-10-19 重庆德方信息技术有限公司 人体细胞染色过程监控系统及方法
WO2023018085A1 (ko) * 2021-08-10 2023-02-16 주식회사 루닛 병리 슬라이드 이미지와 관련된 정보를 출력하는 방법 및 장치
US20250035635A1 (en) 2022-03-17 2025-01-30 Institut National De La Sante Et De La Recherche Medicale Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
US12173081B2 (en) 2023-03-21 2024-12-24 Biograph 55, Inc. CD19/CD38 multispecific antibodies
CN116646088B (zh) * 2023-07-27 2023-12-01 广东省人民医院 一种预测方法、装置、设备及介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000501184A (ja) * 1995-11-30 2000-02-02 クロマビジョン メディカル システムズ,インコーポレイテッド 生体標本の自動画像分析の方法および装置
EP1777523A1 (en) * 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
EP1969338B1 (en) * 2005-12-19 2016-08-24 Ventana Medical Systems, Inc. Automated label printing for tissue specimen slides
CA2737116C (en) * 2008-09-16 2019-01-15 Historx, Inc. Reproducible quantification of biomarker expression
FR2964744B1 (fr) * 2010-09-10 2015-04-03 Univ Versailles St Quentin En Yvelines Test pronostic de l'evolution d'une tumeur solide par analyse d'images

Also Published As

Publication number Publication date
KR20150023760A (ko) 2015-03-05
BR112014031143A2 (pt) 2017-08-08
ES2902879T3 (es) 2022-03-30
SG11201408107RA (en) 2015-01-29
BR112014031143B8 (pt) 2022-11-22
JP6449765B2 (ja) 2019-01-09
CN104541167B (zh) 2018-05-01
AU2013276470A1 (en) 2014-11-27
US20150153349A1 (en) 2015-06-04
AU2013276470B2 (en) 2018-06-07
US10317408B2 (en) 2019-06-11
EP2861986A1 (en) 2015-04-22
JP2015525349A (ja) 2015-09-03
BR112014031143B1 (pt) 2022-03-03
KR102179848B1 (ko) 2020-11-17
CA2873278A1 (en) 2013-12-19
CA2873278C (en) 2021-10-26
IL235738B (en) 2019-02-28
EP2861986B1 (en) 2021-11-10
CN104541167A (zh) 2015-04-22
IL235738A0 (en) 2015-01-29
WO2013186374A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
DE13731071T1 (de) Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen
JP2015525349A5 (enExample)
DE102011004598A1 (de) Verfahren und Computersystem zur Streustrahlkorrektur in einem Multi-Source-CT
DE102013224310A1 (de) Verfahren und System zum Erhöhen eines dynamischen Nutzbereichs einer Spektrometrievorrichtung
DE102010004384A1 (de) Verfahren zur Ermittlung von der Berechnung eines Bestrahlungsplans zugrunde zu legenden Informationen und kombinierte Magnetresonanz-PET-Vorrichtung
EP3137598A1 (de) Gewinnung von gehirnregion-spezifischen neuronalen kulturen aus dreidimensionalen gewebekulturen von stammzellen
DE202013002484U1 (de) Vorrichtung zur volumetrischen Vermessung eines Schlachttierkörperobjekts
Chen et al. Quantitative 3D structural analysis of the cellular microstructure of sea urchin spines (II): Large-volume structural analysis
DE102022000957A1 (de) Baueinheiten für maschinelle lernmodelle zum entrauschen von bildern, sowie systeme und verfahren zu deren verwendung
DE102014208411A1 (de) Auswertung eines während einer Mammographie erzeugten Röntgenbildes einer Brust
Sultan et al. A segmentation-free machine learning architecture for immune land-scape phenotyping in solid tumors by multichannel imaging
Martínez-Pérez et al. There is no general model for occlusal kinematics in conodonts
Dellaert et al. Uncovering the effects of symbiosis and temperature on coral calcification
DE102015206630A1 (de) Multispektrale CT-Bildgebung
DE102017221924B3 (de) Verfahren zur Fusionierung eines Analysedatensatzes mit einem Bilddatensatz, Positionierungseinrichtung und Computerprogramm
EP3126819A1 (de) Vorrichtung und verfahren zur untersuchung einer probe zur prostatatumorerkennung
DE102015215778B4 (de) Verfahren zu einer Darstellung von Magnetresonanz-Daten
Heiny Socio-economic conditions of rural Georgian households and their behavioral intentions regarding tourism development: an empirical analysis
DE102015203537B3 (de) Vorrichtung und Verfahren zur Überprüfung eines Materials für eine Transplantation
DE102023123433B4 (de) Arzneimittelscreening unter Verwendung eines an Proben von Probanden erzeugten Responsom-Profils
Cooper et al. Three-Dimensional Microstructural Imaging of Bone: Technological Developments and Anthropological Applications
DE102012100065A1 (de) Verfahren zur Analyse von Proben und Systeme hierfür
Kalkan et al. Preliminary investigations on crustaceans associated with the Mediterranean mussel (Mytilus galloprovincialis Lamarck, 1819) beds in the upper infralittoral of the Bosphorus (Turkey)
EP2793188A3 (de) Verfahren und System zur Verarbeitung von MRT-Daten des menschlichen Gehirns
DE102008036814A1 (de) Klassifizierungsverfahren und Klassifizierungseinheit für Objektgruppen und/oder Gewebemerkmalsgruppen sowie Verfahren zur Ermittlung von Entwicklungsdaten